Teaching NeuroImage: Axial muscle atrophy in adult-onset Pompe disease
Bashar Katirji, MD,
Vita Kesner, MD, PhD,
Rana B. Hejal, MD and
Amer Alshekhlee, MD, MSc
From Neurological Institute (B.K., V.K., A.A.) and Division of Pulmonary and Critical Care Medicine (R.B.H.), University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH.
Address correspondence and reprint requests to Dr. Amer Alshekhlee, Department of Neurology, University Hospitals Case Medical Center, Case Western Reserve University, 11100 Euclid Avenue, Cleveland, OH 44106-5040 amer.alshekhlee{at}uhhospitals.org
A 38-year-old man presented with a 2-year history of dyspnearesulting in hypercarbic respiratory failure. CT scan of thechest displayed atrophy of the thoracic paraspinal and chestwall muscles (figure). He had neck and abdominal muscle weaknesswith normal limbs strength. Creatine kinase was increased (704IU/L; normal 0 to 240). Electromyography showed insertionalmyotonic discharges in paraspinal muscles without voluntarymotor unit activity. Biopsy of the deltoid muscle demonstratedscarce lysosomal glycogen accumulation. Acid-alpha-glucosidaseactivity in a dried blood spot was reduced (0.59 to 3.88 pmol/punch/hour;normal: 10.00 to 48.96).
Figure Noncontrast CT scan of the chest showing severe atrophy with fat replacement of the paraspinal (arrows) and chest wall muscles in the patient (A) compared to an age-matched normal subject (B)
Adult-onset Pompe disease is a rare, potentially treatable glycogenstorage disorder.1 It may be overlooked because of the preferentialinvolvement of the axial muscles resulting in truncal muscleweakness and respiratory failure.2
Disclosure: The authors report no conflicts of interest.
Kishnani PS, Corzo D, Nicolino M, et al. Recombinant human acid alpha-glucosidase: major clinical benefits in infantile-onset Pompe disease. Neurology 2007;68:99–107.[Abstract/Free Full Text]
Hagemans ML, Hop WJ, Van Doorn PA, et al. Course of disability and respiratory function in untreated late-onset Pompe disease. Neurology 2006;66:581.[Abstract/Free Full Text]